292 related articles for article (PubMed ID: 2168554)
21. Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane.
Mastroianni A; Invernizzi L; Tagliabue E; Fassina G; Albini A; Ménard S; Colnaghi MI
Tumour Biol; 1993; 14(5):279-87. PubMed ID: 8235307
[TBL] [Abstract][Full Text] [Related]
22. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
Ali MA; Rosati R; Pettit GR; Kalemkerian GP
Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
[TBL] [Abstract][Full Text] [Related]
23. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
Khan MZ; Freshney RI; McNicol AM; Murray AM
Ann Oncol; 1993 Jun; 4(6):499-507. PubMed ID: 8394737
[TBL] [Abstract][Full Text] [Related]
24. Laminin promotes formation of cord-like structures by Sertoli cells in vitro.
Hadley MA; Weeks BS; Kleinman HK; Dym M
Dev Biol; 1990 Aug; 140(2):318-27. PubMed ID: 2373256
[TBL] [Abstract][Full Text] [Related]
25. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
26. Use of a reconstituted basement membrane to study the invasiveness of tumor cells.
Iwamoto Y; Sugioka Y
Adv Exp Med Biol; 1992; 324():141-9. PubMed ID: 1283496
[TBL] [Abstract][Full Text] [Related]
27. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
28. Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells.
Song SY; Nomizu M; Yamada Y; Kleinman HK
Int J Cancer; 1997 May; 71(3):436-41. PubMed ID: 9139881
[TBL] [Abstract][Full Text] [Related]
29. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6.
Prévost G; Bourgeois Y; Mormont C; Lerrant Y; Veber N; Poupon MF; Thomas F
Life Sci; 1994; 55(2):155-62. PubMed ID: 8015359
[TBL] [Abstract][Full Text] [Related]
30. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).
Iwamoto Y; Nomizu M; Yamada Y; Ito Y; Tanaka K; Sugioka Y
Br J Cancer; 1996 Mar; 73(5):589-95. PubMed ID: 8605091
[TBL] [Abstract][Full Text] [Related]
32. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.
Curt GA; Jolivet J; Carney DN; Bailey BD; Drake JC; Clendeninn NJ; Chabner BA
J Clin Invest; 1985 Oct; 76(4):1323-9. PubMed ID: 2414316
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix.
Passaniti A; Isaacs JT; Haney JA; Adler SW; Cujdik TJ; Long PV; Kleinman HK
Int J Cancer; 1992 May; 51(2):318-24. PubMed ID: 1568798
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration.
Yamada KM; Kennedy DW; Yamada SS; Gralnick H; Chen WT; Akiyama SK
Cancer Res; 1990 Aug; 50(15):4485-96. PubMed ID: 2369727
[TBL] [Abstract][Full Text] [Related]
37. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
Yamamura K; Kibbey MC; Kleinman HK
Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
[TBL] [Abstract][Full Text] [Related]
38. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane.
Tani T; Lumme A; Linnala A; Kivilaakso E; Kiviluoto T; Burgeson RE; Kangas L; Leivo I; Virtanen I
Am J Pathol; 1997 Nov; 151(5):1289-302. PubMed ID: 9358755
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
